The paper that appears to have triggered the Trump administration’s obsession with hydroxychloroquine as a treatment for infection with the novel coronavirus has received a statement of concern from the society that publishes the journal in which the work appeared.  The April 3, 2020, notice, from the International Journal of Antimicrobial Agents, states that the … Continue reading Hydroxychloroquine-COVID-19 study did not meet publishing society’s “expected standard”